Adenocarcinoma In Situ — Trials

Adenocarcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 31
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–34 of 34 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07711847	Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy(SHIELD)	recruiting	N/A	30	HeroSupport SAINDUSTRY	1	Sep 23, 2026	clinicaltrials
NCT02620852	Women Informed to Screen Depending on Measures of Risk (Wisdom Study)(WISDOM)	recruiting	N/A	100,000	University of California, San FranciscoOTHER	1	Sep 21, 2026